Status:
COMPLETED
Treatment of Cryptosporidiosis
Lead Sponsor:
International Centre for Diarrhoeal Disease Research, Bangladesh
Collaborating Sponsors:
University of Virginia
Conditions:
Cryptosporidiosis
Eligibility:
All Genders
12-36 years
Phase:
NA
Brief Summary
Background: 1. Burden: Cryptosporidiosis among the top 10 causes of diarrhea in the 1st year of life in low and middle-income countries (LMICs), with an estimated total of 48,000 annual deaths an...
Detailed Description
Background: Reports from longitudinal birth cohort study at Bangladesh show that 77% of children experience at least one incidence of cryptosporidiosis in the first two years of life. Cryptosporidiosi...
Eligibility Criteria
Inclusion
- • Children will be enrolled with cryptosporidium infection positive from Mirpur, Dhaka, Bangladesh and whose parents or legal guardian will give consent.
Exclusion
- Participants with history of prior antibiotic use before enrollment
- Participants suffering from Severe Acute Malnutrition, with a WHO median weight for length Z score (WLZ) of less than -3 or having bilateral pedal edema).
Key Trial Info
Start Date :
February 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2023
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT04103216
Start Date
February 1 2020
End Date
August 31 2023
Last Update
October 16 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Icddr,B
Dhaka, Bangladesh, 1212